✦ LIBER ✦

Advantages of reconceptualizing schizophrenia in clinical practice

✍ Scribed by Kenneth M. Weiss

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 603 KB
Volume: 46
Category: Article
ISSN: 0021-9762
DOI: 10.1002/1097-4679(199001)46:1<21::aid-jclp2270460104>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic advantages of monitoring pla

Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice

✍ Lars Bolvig Hansen; Niels-Erik Larsen 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 401 KB

Two hundred and twenty-eight acute paranoid psychotic in-patients received continuous treatment with perphenazine for a period of at least 5 weeks, before blood samples were taken to determine perphenazine plasma levels and conclusions regarding therapeutic efficacy and motor side effects. Patients

Ways of knowing in clinical practice

✍ Ruth G. Dean 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 769 KB

Assessing cognitive function in clinical

Assessing cognitive function in clinical trials of schizophrenia

✍ Jennifer H. Barnett; Trevor W. Robbins; Verity C. Leeson; Barbara J. Sahakian; E 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Cognitive dysfunction in schizophrenia is an important target for novel therapies. Effectively measuring the cognitive effects of compounds in clinical trials of schizophrenia could be a major barrier to drug development. The Measurement and Treatment Research to Improve Cognition in Schizophrenia (

Triptans: the experience of a clinical p

Triptans: the experience of a clinical pharmacologist in clinical practice

✍ Luigi Alberto Pini; Arrigo F. G. Cicero 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 51 KB

Discontinuation of rivastigmine in routi

Discontinuation of rivastigmine in routine clinical practice

✍ Suzanne V. Frankfort; Bregje A. Appels; Anthonius de Boer; Linda R. Tulner; Jos. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

## Background: Rivastigmine is used for symptomatic treatment of mild-to-moderately severe alzheimer's dementia (ad). we investigated the frequency of and reasons for rivastigmine discontinuation in clinical practice and possible predictive factors for discontinuation within the first six months af

Assessment of clinical skills in medical

Assessment of clinical skills in medical practice

✍ Dr. Peter V. Scoles; Dr. Richard E. Hawkins; Dr. Anthony LaDuca 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 841 KB